HSA Approves WINREVAIR for the Treatment of Adults with Pulmonary Arterial Hypertension
MSD (known as Merck & Co., Inc., Rahway, N.J., USA [NYSE: MRK] in the United States and Canada) announced today that the Health Sciences Authority (HSA) of Singapore has approved…